IPP Bureau
Centre deploys high level team to Mumbai to take stock of Measles cases
By IPP Bureau - November 10, 2022
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
ASG Eye Hospitals enters Haryana and expands footprint in UP
By IPP Bureau - November 10, 2022
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
Lupin Q2 FY2023 revenue remains flat
By IPP Bureau - November 10, 2022
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
LANXESS to showcase Biosecurity Solutions at EuroTier 2022
By IPP Bureau - November 10, 2022
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
AGC to establish Life Science Company in 2023
By IPP Bureau - November 10, 2022
The Group will continue to make proactive investments of its management resources in the life science business
Solvay partners with Ostium in single-use surgical instruments material recycling
By IPP Bureau - November 09, 2022
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
Themis Medicare revenue down 15.26%; Profit down 7.76%
By IPP Bureau - November 09, 2022
For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%
Lupin receives tentative approval from USFDA for Doxycycline Capsules
By IPP Bureau - November 09, 2022
Doxycycline Capsules (RLD Oracea) had estimated annual sales of US $215 million in the US
Zydus receives USFDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets
By IPP Bureau - November 09, 2022
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Sun Pharmaceutical gets OAI from USFDA for Mohali facility
By IPP Bureau - November 09, 2022
Piramal Phamra reports Q2 FY23 consolidated loss at Rs. 37.34 Cr
By IPP Bureau - November 09, 2022
Ami Organics Q2 FY23 revenue up 20.2%; Profit up 9%
By IPP Bureau - November 08, 2022
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
Vinati Organics consolidated Q2FY23 PAT up 43% at Rs. 116 Cr
By IPP Bureau - November 08, 2022
The company posted net profit of Rs.81.33 crores for the quarter ended September 30, 2021.
SeQuent Scientific to acquire 100% stake in Tineta Pharma
By IPP Bureau - November 08, 2022
The acquisition is for an enterprise value of Rs. 218 crores
Apollo Hospital launches Vertigo and Balance Disorder clinic in Hyderabad
By IPP Bureau - November 08, 2022
